Compare · EUCRU vs RELX
EUCRU vs RELX
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCRU) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EUCRU operates in Finance, while RELX operates in Consumer Discretionary - the two are in different parts of the market.
- RELX carries a market cap of $67.35B.
- RELX has hit the wire 4 times in the past 4 weeks while EUCRU has been quiet.
- RELX has more recent analyst coverage (15 ratings vs 0 for EUCRU).
- Company
- Eucrates Biomedical Acquisition Corp.
- RELX PLC PLC
- Price
- -
- -
- Market cap
- -
- $67.35B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2015
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 15
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest EUCRU
No recent items for Eucrates Biomedical Acquisition Corp..
Latest RELX
- Erste Group initiated coverage on RELX
- LexisNexis Risk Solutions Introduces Know Your Agent Intelligence to Help Government Agencies Navigate the Rise of AI Agents
- LexisNexis Risk Solutions Launches Accurint One, Reimagining the Future of Law Enforcement Investigations
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- RELX downgraded by Citigroup
- Disclosure Management Suite Launched in Intelligize+ AI to Move Teams from Research to Filing Readiness
- SEC Form 6-K filed by RELX PLC PLC